These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2097894)

  • 1. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG; Mancino M; Monti G
    Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic evaluation of 24 month course of sublingual immunotherapy.
    Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
    Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D; Misirligil Z; Gürbüz L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
    Ebner H; Neuchrist C; Havelec L; Kraft D
    Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
    Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
    Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [House dust mite allergy].
    Urbanek R; Behrle M; Kuhn W
    Padiatr Padol; 1991; 26(1):25-30. PubMed ID: 2057207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T; Mayer J
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
    Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
    Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.